Shanxi Kangbao Biological Product Co., Ltd.
6 clinical trials · Sponsor
◉ Watch Shanxi Kangbao Biological Product Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals (NCT07433387) | Shanxi Kangbao Biological Product Co., Ltd. | 2026-01-29 |
| Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients (NCT06560489) | Shanxi Kangbao Biological Product Co., Ltd. | 2024-09-02 |
| Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients. (NCT06061536) | Shanxi Kangbao Biological Product Co., Ltd. | 2023-11-02 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Subjects (NCT05933824) | Shanxi Kangbao Biological Product Co., Ltd. | 2023-07-13 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients (NCT04592315) | Shanxi Kangbao Biological Product Co., Ltd. | 2021-01-23 |
Track Shanxi Kangbao Biological Product Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.